Selected article for: "epidemic area and main epidemic area"

Author: Weiping Ji; Gautam Bishnu; Zhenzhai Cai; Xian Shen
Title: Analysis clinical features of COVID-19 infection in secondary epidemic area and report potential biomarkers in evaluation
  • Document date: 2020_3_13
  • ID: 1frc4zya_16_1
    Snippet: epidemic area may occur after the primary epidemic in the main epidemic area, its toxicity and pathogenicity may be weakened. CRP can be used as a predictive factor prior to changes in leukocytes, lymphocytes, neutrophils and other inflammatory-related blood parameters to comprehensively evaluate the occurrence and development of COVID-19 infection......
    Document: epidemic area may occur after the primary epidemic in the main epidemic area, its toxicity and pathogenicity may be weakened. CRP can be used as a predictive factor prior to changes in leukocytes, lymphocytes, neutrophils and other inflammatory-related blood parameters to comprehensively evaluate the occurrence and development of COVID-19 infection.

    Search related documents:
    Co phrase search for related documents
    • development occurrence and epidemic area: 1
    • development occurrence and infection development occurrence: 1, 2, 3, 4, 5, 6
    • development occurrence and infection development occurrence evaluate: 1
    • development occurrence and main epidemic area: 1
    • development occurrence and main epidemic area primary epidemic: 1
    • development occurrence and main epidemic area primary epidemic occur: 1
    • development occurrence and pathogenicity toxicity: 1
    • development occurrence and primary epidemic: 1
    • epidemic area and infection development occurrence: 1
    • epidemic area and infection development occurrence evaluate: 1
    • epidemic area and main epidemic area: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • epidemic area and main epidemic area primary epidemic: 1
    • epidemic area and main epidemic area primary epidemic occur: 1
    • epidemic area and pathogenicity toxicity: 1
    • epidemic area and primary epidemic: 1, 2, 3, 4
    • infection development occurrence and main epidemic area: 1
    • infection development occurrence and main epidemic area primary epidemic: 1
    • infection development occurrence and main epidemic area primary epidemic occur: 1
    • infection development occurrence and pathogenicity toxicity: 1